I do. But I think there is still room for dividend.
Plus, like many other down-rampers said this litigation has low success rate, why bother throwing too much money out. I will cautiously judge tomorrow's dividend decision accordingly
Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX, page-18
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 141072 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 73455 | 1 |
View Market Depth
| Last trade - 09.59am 10/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable